marijuana stocks

ENDEXX Corp. (EDXC)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
Total Revenue 35   –   –   –  
Cost of Revenue – – – –
Gross Profit 35   –   –   –  
Operating Expenses
Research Development 50 64 2 0
Selling General and Administrative 252 178 99 64
Non Recurring – – – –
Others 0 0 0 0
Total Operating Expenses – – – –
Operating Income or Loss (268) (243) (101) (65)
Income from Continuing Operations
Total Other Income/Expenses Net 0 36 0 232
Earnings Before Interest And Taxes (267) (207) (333) 167
Interest Expense – – – –
Income Before Tax (267) (207) (333) 167
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (267) (207) (333) 399
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (267) (207) (101) 167  
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (267) (207) (101) 167

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

The Alkaline Water Company Inc. (WTER) (WTER.V) Partners with Centuria Foods to Expand CBD Infused Product Portfolio

The Alkaline Water Company Partners with Centuria Foods to Expand CBD Infused…

$MYEC Named a 2015 PYMNTS Innovator

MyECheck Named a 2015 PYMNTS Innovator Pioneer of the fully electronic check…

High Tide Inc. (HITI) Subsidiary Blessed CBD Launches Sales of Hemp-derived CBD Products

High Tide Subsidiary Blessed CBD Launches Sales of Hemp-derived CBD Products on…

$PMCB Raises Additional $1 Million for Pancreatic Cancer Clinical Trial

PharmaCyte Biotech Raises Additional $1 Million for Pancreatic Cancer Clinical Trial PharmaCyte…